Our immunogenomic analyses and initial identification of elevated SYNGR3 expression in HPV(+) HNSCs indicated that it is highly expressed within the Th1 subset of tumor-infiltrating T cells (Fig. 1C). Here, SYNGR3 is linked to neoplasm.